Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R2-ICE in Relapsed/Refractory DLBCL
NCT02628405Phase 2Active, not recruiting
- Sponsor
- Academic and Community Cancer Research United
- Start
- May 2016
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in diffuse large B-cell lymphoma (DLBCL), sponsored by Academic and Community Cancer Research United. Started May 2016; status: active, not recruiting.
02
Drugs
lenalidomide
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT02628405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02628405.